semaglutide coming off shortage list On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, compounding Generic Semaglutide in USA (2026):
Description
The specific manufacturer, the volume commitments, and the quality control relationship all feed into end-buyer pricing
Treatment plans are structured for ongoing monitoring and adjustment based on patient response
Not valid for residents of AL, AK, CA, HI, LA, MS, and Canada
Shima Hadidchi MD is now providing Mounjaro tirzepatide injections for weight loss
12 pounds of sustainable weight loss can be impressive, but it may not be significant enough to warrant the side effects and health risks that the drug poses to users
